Market Pulse
Director dealings: Ecora executives buy shares, Card Factory CEO covers tax bill
Ecora Resources and Card Factory both announced significant transactions involving their directors on Monday.
Europe close: Stocks reverse earlier losses to end up
European shares reversed earlier losses to end up on Monday, with Topdanmark surging ahead after Finnish insurer Sampo agreed to buy its Danish rival for $4. 7bn.
US open: Stocks flat to slightly higher; Empire State manufacturing in focus
US stocks were flat to slightly higher in early trade on Monday following record highs last week.
Cornish Metals agrees sale of Nickel King Property
Cornish Metals announced on Monday that it has entered into a binding letter of intent with Northera Resources for the sale of its 100% interest in the Nickel King and Opescal Lake properties, collectively known as the Nickel King Property.
FTSE 100 movers: Utilities, miners in the red
London’s FTSE 100 was down 0. 2% at 8,127. 26 in afternoon trade on Monday.
Invinity inks battery sale with PowerFlex in California
Invinity Energy Systems announced a significant sale of 4 MWh to PowerFlex, part of EDF Renewables North America, on Monday.
Jefferies cuts Aston Martin price target, shares slump
Jefferies cut its price target on Aston Martin Lagonda shares on Monday to 250p from 275p as it pointed to reduced earnings and delayed deleveraging.
Lexington Gold upbeat on assay results from Jennings-Pioneer project
Explorer and developer Lexington Gold announced positive assay results from its recent drilling programme at the Jennings-Pioneer Project in South Carolina on Monday.
London midday: Stocks dip as investors eye UK inflation, BoE
London stocks had dipped into the red by midday on Monday as worries about French political uncertainty crept in again, and as investors eyed a key UK inflation reading and the latest policy announcement from the Bank of England later in the week.
Mind Gym confident despite swinging to losses
Mind Gym reported on a challenging year in which it swung to losses on Monday, while also outlining a new strategy aimed at medium-term growth and profitability.
RBC Capital continues to see ‘significant’ upside for Rentokil
RBC Capital Markets said on Monday that it continues to see "significant" upside for Rentokil Initial shares, "although clearly there is still lots to do, with peak branch integration still 12 months away".
Goldman Sachs downgrades SSP to ‘sell’, prefers WH Smith
Goldman Sachs downgraded SSP on Monday to ‘sell’ from ‘neutral’ "on a relative basis" as it took a look at European travel concessions.
Fulcrum kicks off phased test programme at Sylvanite project
Canada-focussed mineral exploration and development company Fulcrum Metals announced the start of a phased sampling, testing, and study programme at its Sylvanite Gold Tailings project in the Kirkland Lake area of Ontario on Monday.
Asia report: Markets fall as investors digest wave of China data
Asia-Pacific markets were primarily in the red on Monday, as investors digested key economic data from China.
UBS to book $900m provision over Greensill supply financing funds
Swiss banking giant UBS announced on Monday that it expected to book a provision of about $900m related to Credit Suisse's funds, tied to the collapsed supply chain financing firm Greensill Capital.
Citi downgrades European equities to ‘neutral’
Citi downgraded its stance on European equities on Monday to ‘neutral’ from ‘overweight’ as it said near-term risks have increased, with markets narrowing and political uncertainty taking centre stage.
Somero trading in line with expectations
Somero Enterprises said in an update on Monday that trading for the first five months of 2024 was consistent with expectations.
London open: Stocks gain as investors eye CPI, BoE decision
London stocks rose in early trade on Monday as investors eyed a key UK inflation reading and the latest policy announcement from the Bank of England later in the week.
Mission Group trading as expected as it works on savings plan
Mission Group said in an update on Monday that trading between 3 April and 17 June had remained in line with the board's expectations.
Hutchmed publishes positive sovleplenib trial results
Hutchmed China announced the publication of positive results from its phase three ‘ESLIM-01’ trial of sovleplenib in the Lancet Haematology.